NCT00842153

Evaluation of the Efficacy and Tolerability of Clobetasol Propionate Foam Compared to Vehicle Foam

A Study to Evaluate the Efficacy and Tolerability of Clobetasol Propionate vs. Vehicle in the Treatment of Mild to Moderate Plaque-Type Psoriasis

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 58 (actual)
• Sponsor: Stiefel, a GSK Company · Industry
• Sex: All
• Age: 12 Years
• Healthy volunteers: Not accepted

Summary

The purpose of the study is to compare the efficacy and safety of Clobetasol propionate to that of its Vehicle in the treatment of mild to moderate plaque-type psoriasis.

Detailed description

The purpose of the study is to compare the efficacy and safety of Clobetasol propionate to that of its Vehicle in the treatment of mild to moderate plaque-type psoriasis. This is a multi-center, double blind, randomized, parallel designed study which consists of 2 weeks of treatment and a follow-up visit 2 weeks later.

Conditions

• Psoriasis

Interventions

Type	Name	Description
DRUG	Clobetasol propionate foam	Topical Clobetasol propionate foam
DRUG	Vehicle foam	Vehicle foam does not include the active drug.

Timeline

• Start date: 2007-11-01
• Primary completion: 2007-12-01
• Completion: 2008-01-01
• First posted: 2009-02-12
• Last updated: 2017-10-09
• Results posted: 2012-01-30

Locations

2 sites across 1 country: United States